chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had moderate reaction to first vaccine where I had to go to the ER, for rash on my arm and chest/back, increase blood pressure and chest pain. Pepcid, benadryl and prednisone were given to me in the ER and a liter of fluids. VAERS number Date Form Completed: 01/06/2021 Temporary VAERS E-Report No: 223935  So on the second dose, I premedicated the night before 8pmwith 20mg of prednisone, 10mg of claritin, and 40mg of pepcid. In the morning 9am I took 40 mg of pepcid, 20 mg of predisone and 30 minutes prior to second vaccine around 12pm, I took 25mg of benadryl.  After vaccine , I had severe nausea at about 20 minutes (1240p),  and increase blood pressure at about 30 to 40 minutes. 156/94 was my highest. I had fewer areas of itching and specks of rash and itching around my back than on the first dose that I took.   If I did not premediate, I am sure I would have had a similar or worse reaction since I still had similar reaction but milder.
Patient woke up dizzy, didn't eat or drink but doesn't usually in the AM, went to class, felt dizzy and thirsty. Left class to go outside and just outside the door patient fainted, woke up sweating. Walked back to the dorm but felt weak. Went to health Centre (ambulatory) at 11:30/12:00 noon. Complained of being lightheaded and dizzy. Hypotension when changing position. BP 118/76 (lying and sitting); 112/73 (standing), Pulse-80, strong. Patient felt short of breath at one point prior to arrival. Patient also complained of a  headache. She was not feeling any better. Injections from the Td vial was given to three other patients, there were no other reports of reactions. Follow up on 09/21/06: Patient came back into the office on 09/20/06 and was perfectly fine. Patient was a little dizzy over the weekend but had fully recovered. Reporter was not sure when the patient was diagnosed with possible scarlet fever. Patient noticed rash around 08/09/06 and went to see a doctor between 20th and 25th of August. No labs were done.
This spontaneous report as received from a pharmacist refers to a 65 year old female patient. On 23-JAN-2014 the patient was vaccinated with a dose of ZOSTAVAX 0.65 ml injection, subcutaneously, left arm (lot # J011882, expiration date 04-JAN-2015). On 25-JAN-2014 the patient experienced an injection site reaction involving tenderness, swelling and pox-like blisters around injection site. The patient sought medical attention and was seen by her physician who treated with cold compresses and cephalexin. None lab diagnostics were performed. The outcome of events was not reported. The relatedness between vaccination with ZOSTAVAX and events was not reported. Additional information has been requested.
Right upper arm red, hot, swollen 18 cm x 18 cm the circumference of arm. 5 small fluid filled vesicles around injection site. Patient c/o pain in effected arm. No systemic s/s. Doctor name reported examined patient and recommended Advil for pain ice to effected area. Advised to go to E.R. if symptoms worsened or systemic involvement occurs and contact PCP.
3 hours after HPV #1 and influenza vaccine -> nausea, emesis, diarrhea.
I started feeling muscle ache around 10hrs after the injection of 2nd dose. Shortly after, the whole body was aching and I started experiencing fever-like symptom throughout the night. can't sleep well due to persistent muscle pain. When I got up the next morning (4/11) at around 7:30am, I felt dizzy and experienced an episode of hypoglycemia. the whole body muscle pain lasted for the entire morning until I took 1 pill of 200mg ibuprofen. by Sunday evening (4/11), most of the side effects were gone.
QUARTER SIZE LUMP AT INJECTION SITE; SWELLING AT INJECTION SITE (ABOUT A DIAMETER OF BASEBALL); This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286 expiry: 06-SEP-2021) dose was not reported, administered on 06-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-JUL-2021, the subject experienced quarter size lump at injection site. On 07-JUL-2021, the subject experienced swelling at injection site (about a diameter of baseball). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling at injection site (about a diameter if baseball) on JUL-2021, and was recovering from quarter size lump at injection site. This report was non-serious.
After one and half months of receiving my 5th dose. On 01/09/2023 at night 10:00PM I started having had chills, sore throat, fever, muscles aches, exhausted, irritable mood swing, and hip weakness. I wasn't sure what was happening to me so I schedule an appointment with my doctor on 01/26/2023. He did all kinds of tests including COVID-19, RSV, Strep, and Flu. All the tests came out negative. I also had a fast heat rate. My doctor didn't prescribe me any medication but referred me right away to an Endocrinologist. I went to the Endocrinologist on 01/30/2023. After going through several tests the doctor diagnosed me for Thyroiditis. I had Hyperthyroidism. The doctor prescribed me with naproxen, 21 dose pack medication similar to prednisone, and propranolol. On 02/27/2023 I went for a follow up again to the Endocrinologist after testing me again. On 02/28/2023 the test result showed that now I have Hypothyroidism. Now my muscle pain is getting better and I am not taking any medications at this moment because I am waiting for my next follow up which is on March 13/2023 for farther discussion and medication.
pt recvd vax; at time of injection her back arched; eyes rolled back & mouth opened but no sound came out; pt then began to cry w/in 10 min was calm; 2 hrs later appear lathagic then went into high pitch screaming; stopped breathing & died;
Information has been received from a licensed practical nurse concerning an 8 year old female who on 15-JUN-2007 was vaccinated SC on right deltoid with a first dose of zoster vaccine live (Oka/Merck) (Lot #656607/0163U).  It was reported that the patient was supposed to receive second dose of varicella virus vaccine live (Oka/Merck) (MSD).  It was reported that it was human error not a product confusion.  Additional information stated that the patient had no reaction.  No further information is expected.  the patient's siblings had similar experience after therapy with zoster vaccine live (MSD) WAES# 0707USA01867 and WAES #0706USA02773.
This spontaneous report was received from a healthcare worker regarding an unspecified 6 patients of unknown age and gender. This report pertains to the patient who on 03-DEC-2013 was vaccinated with a dose of M-M-R II, (lot # J003002, expiry date 14-MAR-2015) (dosage regimen unspecified). The healthcare worker reported that 6 clients were vaccinated with the same lot of improperly stored M-M-R II. The healthcare worker reported details of a supported temperature excursion for M-M-R II that were exposed to temperatures of 47 Fahrenheit (F) for 1 hour 48 minutes (min), 48.5F for 1 hour 13 min, and 48.5F 1 hour 13 min (also reported as the vaccine was not stored improperly, the products would not be adversely affected by this specific temperature excursion). No adverse effect reported. No further information was available. This case is linked to 1312USA005771, 1312USA010204, 1312USA0210205, 1312USA010207 (Same reporter link). Additional information has been requested.
hives, itching, scabbing, shedding, all over entire body; hives, itching, scabbing, shedding, all over entire body; hives, itching, scabbing, shedding, all over entire body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 17Oct2021 (Lot number: FF2593) at the age of 40 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Prev dose product: Covid-19, Prev dose brand: Pfizer, Prev dose brand unknown: False, Prev dose lot number: FF2587, Prev dose lot unknown: False, Prev dose administration date: 23Sep2021, Prev dose dose number: 1, Prev dose vaccine location: Left arm), administration date: 26Sep2021, when the patient was 40 years old, for COVID-19 Immunization. The following information was reported: PRURITUS (non-serious), URTICARIA (non-serious), SCAB (non-serious) all with onset 18Oct2021, outcome "not recovered" and all described as "hives, itching, scabbing, shedding, all over entire body". The event "hives, itching, scabbing, shedding, all over entire body", "hives, itching, scabbing, shedding, all over entire body" and "hives, itching, scabbing, shedding, all over entire body" was evaluated at the physician office visit. Therapeutic measures were taken as a result of angioedema, pruritus, urticaria, scab. Adverse event reported was vaccination Shedding: hives, itching, scabbing, shedding, all over entire upper and lower body. Doctor consulted and prescribed antibiotics for 7 days, symptoms did not abate. Adverse event start date was 18Oct2021. Adverse event country was   . Adverse event resulted in doctor or other healthcare professional office/clinic visit. Patient was not recovered. Patient received adverse event treatment of oral antibiotics for 7 days. Covid was not there prior vaccination. No covid tested post vaccination. Known allergies and other medical history were not reported.  No follow-up attempts are possible. No further information is expected.
This spontaneous prospective pregnancy report has been received from a consumer refers to his wife of unknown age, who received numerous vaccines as part of a refugee vaccination program. On 11-DEC-2015, the patient was vaccinated with a dose of HPV vaccine (manufacturer unknown) (product origin unknown) and a dose of hepatitis A vaccine (manufacturer unknown) (dose, route and lot were unknown for the both vaccines). On 06-FEB-2016 the patient was vaccinated with another dose of HPV vaccine (manufacturer unknown) (product origin unknown). Concomitant therapies included DTAP and TENIVAC. It was reported that they now discovered the patient was pregnant (exposure during pregnancy). The last menstrual period (LMP) and Estimated date of delivery (EDD) were not given. The pregnancy outcome was unknown. Additional information is not expected as no contact information was provided.
Very swollen lymph node in left arm; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Mar2021 10:00 (Batch/Lot number: unknown) at the age of 43 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (administration time=10:00 AM, vaccine location =Left arm, dose number =1), administration date: 02Mar2021, when the patient was 43 years old, for COVID 19 Immunisation. The following information was reported: HEADACHE (non-serious) with onset 24Mar2021 10:00, outcome "recovering", described as "Headache"; VACCINATION SITE LYMPHADENOPATHY(non-serious) with onset 25Mar2021 09:00, outcome "recovering", described as "Very swollen lymph node in left arm". Therapeutic measures were not taken as a result of headache, lymphadenopathy.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, Myalgia, Fever, fatigue, lymphadenopathy, chills, decreased appetite.  Narrative:  Other Relevant History:
Information has been received from a health professional concerning a female with NKDA who on 06/18/98 was vaccinated with varicella virus vaccine live. there were no concomitant medications. On 10/20/0, the pt presented with a generalized vesicular rash over entire body No other symptoms were reported. Unspecified medical attention was sought. Additional information has been requested.
NO ADVERSE EVENTS NOTED POST VACCINATION- REPORTING DUE TO <18 YEARS OLD AT TIME OF MODERNA VACCINATION.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 25-MAY-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion two times. The total cumulative excursion time of the first time was 144 hours with the lowest recorded temperature of 34 Fahrenheit degree. The total cumulative excursion time of the second time was 144 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from a other certified medical assistant refers to a patient of unknown age and gender. On 26-AUG-2014, the patient was vaccinated intramuscularly with a 0.5 ml dose of GARDASIL (lot # K004204, exp 12-JAN-2017) that underwent a temperature excursion. No adverse effect was reported. Additional information has been requested.
39 year old female patientwas administered one dose of Gardasil 9; This spontaneous report has  been received from a nurse referring to a 39 year old female patient. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not reported.     On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), intramuscularly (strength, dose, frequency, route of administration, lot number and expiration date were not provided) for prophylaxis.
Patient complains of reduced range of motion in arm and lump or swelling in muscle. Raises arm like a person playing piano and states that's as high as it will go.
Developed severe rash all over body.  First noticed 2 days after vaccine.  Saw MD who felt it was a reaction to the vaccine and prescribed Claritin.  Within 2 weeks the rash was gone.
Light headed/ still feel dizzy; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed/ still feel dizzy), FATIGUE (Fatigue) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headed/ still feel dizzy), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, DIZZINESS (Light headed/ still feel dizzy), FATIGUE (Fatigue) and HEADACHE (Headache) had not resolved.            No concomitant medications were reported. No treatment details were reported. Patient reported that it has been 2 weeks since she had received her second shot and the adverse events are still ongoing.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 01-DEC-2015 at time- 09:05, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 2.6 and 1.7 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
loss of taste and smell; loss of taste and smell; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised and Crohn's disease.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell). At the time of the report, AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, Antibody test: 1200 (High) Done bloodwork after second dose, in July. Level of antibodies was 1200 .. In August 2021, Antibody test: 2500 (High) After 3rd dose, patient did another blood work and level of antibodies was 2500..         Concomitant medication includes Opioids. No treatment medication was provided. Patient said to be immunocompromised and has Chron's disease.  After third dose patient experienced loss of taste and smell.  This case concerns a patient of unknown age and gender, with no relevant medical history, who experienced the non-serious unexpected AESI's of AGEUSIA and ANOSMIA. The events occurred on an unknown date after receiving the third dose of Spikevax. The rechallenge is not applicable since the events have not resolved and no further dose is expected. The benefit-risk relation of Spikevax is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 21-Oct-2021: Significant followup appended, Email address and outcome of events updated.; Sender's Comments: This case concerns a patient of unknown age and gender, with no relevant medical history, who experienced the non-serious unexpected AESI's of AGEUSIA and ANOSMIA. The events occurred on an unknown date after receiving the third dose of Spikevax. The rechallenge is not applicable since the events have not resolved and no further dose is expected. The benefit-risk relation of Spikevax is not affected by this report.
-Headache beginning about 3-4 hours following second vaccination shot. Lasted for nearly 3 days and subsided by end of weekend (shot received Thursday afternoon).   -Low fever of 100-101 degrees that slowly returned to normal range within 36-48 hours.   -Normal/expected soreness in right arm (injection arm) that caused difficulty in mobility and general soreness lasting for about 2-3 days and subsided by end of weekend (again shot was administered on Thursday afternoon).
Pt called on 8/4/2019 and said that her left arm was tender to touch, red, and painful after the injection. She said that she tried NSAIDs and cold compress and her arm is still painful, and cannot move her left arm much. She is advised to talk to her physician on Monday.
had the Moderna vaccine, came down with Covid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (had the Moderna vaccine, came down with Covid) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (had the Moderna vaccine, came down with Covid). At the time of the report, COVID-19 (had the Moderna vaccine, came down with Covid) outcome was unknown.            No concomitant medications were reported. Patient had COVID Friday night, woke up Saturday had just felt like having cold and a week later still felt like just had a cold, never got sick. Patient had the Moderna vaccine, 2 shots and 2 boosters, total of 4 doses. Patient was going to get 3rd booster, but became positive before getting 3rd booster. No treatment information was provided.   Reporter did not allow further contact
Guillain-Barre; IVIg started 6 Nov 2018.
Increase in pulse/heart rate (up to 117 bpm at rest), headache, severe body aches and a rash that lasted approximately a week.
@ 2PM same day pt grew pale, pupils, dilated, couldn't stand; t102.4 R; difficult to stay awake; sx lasted 2 hrs & then dissipated by 5PM:
Within 24 hours of receiving ZOSTAVAX vaccine pt developed extreme fatigue, redness in legs, joint pains hip, ankles, knees, myalgia glut max-pain swelling at injection site.
Fatigue, fever, severe joint pain, nausea. Nurse at doctor's office strongly encouraged me to report this.
Low fever, chills, fatigue, arm soreness still persisting 24 hours after injection
Pt developed erythema macular around the injection site one after the shot. Pt did not developed fever no hives. Area was slightly swollen. Pt was treated with Zyrtec improving. Pt was in the clinic today 7/17/06
Began feeling tired and developed an intense migraine around 6 hours after, went to bed several hours early (8:30 pm).  Intense started in early evening in upper arms and neck and spread through entire body.  Felt as if bones hurt.  In bed 10 hours but got little rest.  Chills and sweats.  Note that the pain is the exact same I had when I had COVID several months ago, which has flared up on and off since.  Next day symptoms are mostly gone, some tiredness and soreness remains.
The pediatric dose of pfizer that was given did not include a dilution. 0.2 mL of undiluted solution was given IM deltoid. Patient has not experienced any adverse events since administration. This was administered only hours ago. Patient's parents were called and informed of the situation. To prevent this error in the future, additional labeling and pharmacy practices will be reviewed to eliminate factors that contributed to  this incident.
Erythema Multiforme; onset 13 days, post varicella vax. Initial lesion over vaccine site.
After receiving the flu vaccine and GARDASIL vaccine, patient had a syncopal episode and fell and hit her head on the floor. The episode lasted around 5-10 seconds. Patient was sent to the ER after recovering well.
p/recvd vax pt lost consciousness & fell to the floor, seizured for approx 15 seconds, regained consciousness p/approx 1 1/2 min; BP @ onset 120/80, P65 weak; ambulance was called pt was treated w/02 & transported to clinic;
Shingles; This spontaneous report was received from a lawyer regarding a case in litigation referring to a currently 58-year-old female patient. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On an unspecified date in 2016 the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (lot#, expiration date, dosage and route of administration were not provided) for the long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient was treated for shingles resulting from her use zoster vaccine live(ZOSTAVAX). At the time of the report, the outcome of shingles was unknown. The reporter considered shingles to be related to Zoster Vaccine Live(ZOSTAVAX).
Fever of 100.4 for two days, headache lasted 3 days. Difficulty breathing while laying down.  Sweating profusely while wearing mask when it didn?t bother me before.  Sweating non stop for three days all over body including back and legs and arms. Muscle ache all over.